Standard Glass Lining IPO Closes Today: Standard Glass Lining Technology IPO has been making waves as it enters its final day of subscription on January 8, 2025. One of the most talked-about aspects of this IPO is its GMP, which gives a short snapshot of investor sentiment ahead of its listing.
Standard Glass Lining Technology IPO – GMP
As the subscription draws to a close, the GMP for Standard Glass Lining IPO is estimating a notable figure. Currently, shares of the company are trading at a premium of Rs 96, indicating a potential listing price of Rs 236 per share. This suggests a potential gain of 68.57% compared to the upper end of the issue price band, which is set at Rs 140 per share.
However, it’s important to note that GMP is an unofficial market indicator and can fluctuate. As of January 7, the GMP stood at Rs 93, indicating a 66% premium over the upper price band.
Standard Glass Lining Technology IPO – Subscription status
As of the latest development, the IPO has already received overwhelming demand. By mid noon, the issue had been subscribed 52.32 times. So far, the retail category has been subscribed 44.18 times, Qualified Institutional Buyers (QIB) category received a subscription rate of 4.72 times and the Non-Institutional Investors (NII) segment managed a subscription rate of 134.77 times so far.,
Standard Glass Lining Technology IPO – Key IPO details
The total issue size is Rs 410.05 crores, comprising a fresh issue of 1.50 crore shares worth Rs 210 crores and an offer for sale (OFS) of 1.43 crore shares worth Rs 200.05 crores. Retail investors can apply for a minimum of 107 shares, which requires an investment of Rs 14,980.
Standard Glass Lining Technology IPO – Allotment and listing
The allotment will be finalised on January 9, 2025 and the listing of the issue on the Indian bourses, BSE and NSE is scheduled on January 13, 2025.
Also Read: Auto stocks: Jefferies top 3 picks could surprise you
About the company
Standard Glass Lining Technology, established in 2012, is a manufacturer of engineering equipment catering to the pharmaceutical and chemical sectors in India. With eight manufacturing units in Hyderabad, the company handles the entire production process in-house, offering a range of products including reaction systems, storage, separation, and drying systems plant, engineering, and services.
The proceeds raised through this IPO will be used for a variety of purposes, including capital expenditure for machinery purchases, repayment of loans, and investments in its subsidiary, S2 Engineering Industry.